首页 | 本学科首页   官方微博 | 高级检索  
     


Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre,open-label,randomised, phase 3 trial
Authors:Graham H Jackson  Faith E Davies  Charlotte Pawlyn  David A Cairns  Alina Striha  Corinne Collett  Anna Hockaday  John R Jones  Bhuvan Kishore  Mamta Garg  Cathy D Williams  Kamaraj Karunanithi  Jindriska Lindsay  Matthew W Jenner  Gordon Cook  Nigel H Russell  Martin F Kaiser  Mark T Drayson  Gareth J Morgan
Affiliation:1. Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK;2. The Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA;3. The Institute of Cancer Research, London, UK;4. The Royal Marsden Hospital NHS Foundation Trust, London, UK;5. Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK;6. Section of Experimental Haematology, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK;7. Heart of England NHS Foundation Trust, Birmingham, UK;8. Leicester Royal Infirmary, Leicester, UK;9. Centre for Clinical Haematology, Nottingham University Hospital, Nottingham, UK;10. University Hospital of North Midlands, Stoke-on-Trent, UK;11. East Kent Hospitals University NHS Foundation Trust, Canterbury, UK;12. University Hospital Southampton NHS Foundation Trust, Southampton, UK;13. Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK;14. Haematological Malignancy Diagnostic Service, St James''s University Hospital, Leeds, UK
Abstract:
Keywords:for the
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号